Leukemia Clinical Trials in Florida

Showing 841-860 of 1,031 trials

TR(ACE) Assay Clinical Specimen Study

NCT02934360

The TR(ACE) Assay is a quantitative in vitro diagnostic test run on the TR(ACE) Instrument intended for the measurement of high molecular weight human DNA from plasma as an aid to monitoring disease progression or response to therapy or recurrent or residual disease.

Carcinoma, Non-Small-Cell LungBreast Neoplasms

Biological Dynamics450 participantsStarted Sep 2016

Encinitas, California, United States • Oceanside, California, United States • Santa Monica, California, United States +13 more locations

Approved For Marketing49 miles

Expanded Access Program of Ponatinib

NCT01592136

This protocol will allow expanded access of ponatinib to patients ≥18 years with chronic myeloid leukemia (CML) any phase or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) who have failed all available treatment options.

Chronic Myeloid Leukemia (CML)Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Ariad Pharmaceuticals

La Jolla, California, United States • San Marcos, California, United States • Vallejo, California, United States +30 more locations

PreviousPage 43 of 52Next

TR(ACE) Assay Clinical Specimen Study

Expanded Access Program of Ponatinib

Leukemia Trials in Other Cities

Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma

A Safety Study of SGN-CD33A in AML Patients

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

A Safety Study of SGN-CD19A for B-Cell Lymphoma

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Cosmesis, Patient Satisfaction and Quality of Life After da Vinci Single Site and Multiport Laparoscopic Cholecystectomy

Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)

Physiologic Definition of Bronchopulmonary Dysplasia

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Other Conditions in Florida